Cargando…

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes

Plasma dihydroceramides are predictors of type 2 diabetes and related to metabolic dysfunctions, but the underlying mechanisms are not characterized. We compare the relationships between plasma dihydroceramides and biochemical and hepatic parameters in two cohorts of diabetic patients. Hepatic steat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carlier, Aurélie, Phan, Franck, Szpigel, Anaïs, Hajduch, Eric, Salem, Joe-Elie, Gautheron, Jérémie, Le Goff, Wilfried, Guérin, Maryse, Lachkar, Floriane, Ratziu, Vlad, Hartemann, Agnès, Ferré, Pascal, Foufelle, Fabienne, Bourron, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762772/ https://www.ncbi.nlm.nih.gov/pubmed/33377125 http://dx.doi.org/10.1016/j.xcrm.2020.100154

Ejemplares similares

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
por: Hajduch, Eric, et al.
Publicado: (2021)

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
por: Qiao, Liping, et al.
Publicado: (2008)

Dihydroceramide Desaturase Inhibition by a Cyclopropanated Dihydroceramide Analog in Cultured Keratinocytes
por: Brodesser, Susanne, et al.
Publicado: (2011)

Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
por: Takahashi, Sadao
Publicado: (2017)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations
por: Williams, Paul T.
Publicado: (2020)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
por: Samson, Clarissa E., et al.
Publicado: (2012)

Characterising the Inhibitory Actions of Ceramide upon Insulin Signaling in Different Skeletal Muscle Cell Models: A Mechanistic Insight
por: Mahfouz, Rana, et al.
Publicado: (2014)

Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2015)

PMON31 IL-4 Serum Levels Correlate with Triglycerides and VLDL in African American males
por: Johnson, Abraham, et al.
Publicado: (2022)

Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response
por: Motte, Alexandre, et al.
Publicado: (2020)

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat
por: Kabagambe, Edmond K., et al.
Publicado: (2012)

LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins: LncRNA with HK1 regulates triglycerides, autophagy and VLDL
por: Wang, Lingling, et al.
Publicado: (2023)

Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats
por: Li, Fang-Fang, et al.
Publicado: (2020)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis
por: Pistorio, Valeria, et al.
Publicado: (2022)

Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides
por: Rayner, Katey J., et al.
Publicado: (2011)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro
por: Siddique, Monowarul M., et al.
Publicado: (2012)

Phosphorylated Dihydroceramides from Common Human Bacteria Are Recovered in Human Tissues
por: Nichols, Frank C., et al.
Publicado: (2011)

PLASMA DIHYDROCERAMIDE SPECIES ASSOCIATE WITH WAIST CIRCUMFERENCE IN MEXICAN AMERICAN FAMILIES
por: Mamtani, Manju, et al.
Publicado: (2013)

Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology
por: Wittenbecher, C., et al.
Publicado: (2022)

Dihydroceramides Derived from Bacteroidetes Species Sensitize TRPV1 Channels
por: Ludwig, Nora, et al.
Publicado: (2023)

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023)

VLDL-associated mutagenic activity.
por: Gomes, M. I., et al.
Publicado: (1982)

Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot’s acute neuroarthropathy
por: Dardari, Dured, et al.
Publicado: (2020)

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome
por: Broedl, Uli C, et al.
Publicado: (2006)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
por: Hernández-Tiedra, Sonia, et al.
Publicado: (2016)

Serum dihydroceramides correlate with insulin sensitivity in humans and decrease insulin sensitivity in vitro
por: Zarini, Simona, et al.
Publicado: (2022)

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010)

Macrophages take up VLDL-sized emulsion particles through caveolae-mediated endocytosis and excrete part of the internalized triglycerides as fatty acids
por: Deng, Lei, et al.
Publicado: (2022)

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
por: Lin, Huige, et al.
Publicado: (2022)

Dihydroceramide desaturase promotes the formation of intraluminal vesicles and inhibits autophagy to increase exosome production
por: Wu, Chen-Yi, et al.
Publicado: (2021)

The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL
por: van Dijk, Peter R., et al.
Publicado: (2019)

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
por: Bourron, Olivier, et al.
Publicado: (2020)

Impaired hypoxic ventilatory drive induced by diabetic autonomic neuropathy, a cause of misdiagnosed severe cardiac events: brief report of two cases
por: Schubert, Louis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_imjcorsud072divcie1eh8kj6a